2021
DOI: 10.1016/j.bbrc.2021.05.103
|View full text |Cite
|
Sign up to set email alerts
|

Verticillin A increases the BIMEL/MCL-1 ratio to overcome ABT-737-resistance in human colon cancer cells by targeting the MEK/ERK pathway

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 40 publications
0
6
0
Order By: Relevance
“…As a digestive tract malignant tumor in the colon, CRC frequently occurs at the junction between rectum and sigmoid colon ( 25 ). CRC occurs in a staged and multi-step way, where the key factors inducing the occurrence and development of CRC are the activation of various oncogenes and the inactivation of tumor suppressor genes ( 26 ).…”
Section: Discussionmentioning
confidence: 99%
“…As a digestive tract malignant tumor in the colon, CRC frequently occurs at the junction between rectum and sigmoid colon ( 25 ). CRC occurs in a staged and multi-step way, where the key factors inducing the occurrence and development of CRC are the activation of various oncogenes and the inactivation of tumor suppressor genes ( 26 ).…”
Section: Discussionmentioning
confidence: 99%
“…The study on the new drug Enduo showed that the drug had a certain therapeutic effect on colon cancer by blocking the ERK signaling pathway to prevent cell migration [18] . Verticillin A increases the ratio of BIMEL/MCL-1 to overcome ABT-737-resistance in human colon cancer cells by targeting the MEK/ERK pathway [19] . PKCα activated RAS upstream of RAF, MEK and ERK, which induced the arrest of the cell cycle in intestinal cells [20] .…”
Section: Discussionmentioning
confidence: 99%
“…Multiple proteins or drugs affected COAD progression via this pathway. For example, Verticillin A could increase the BIM/MCL-1 ratio to overcome ABT-737 resistance in COAD cells by this pathway [ 27 ]. These studies all confirmed that MEK/ERK pathway could serve as a promising target of COAD.…”
Section: Discussionmentioning
confidence: 99%